LabCorp debuts combined COVID-19, flu, and RSV test

By LabPulse.com staff writers

September 9, 2020 -- LabCorp has launched a combined test for COVID-19, influenza A/B, and respiratory syncytial virus (RSV). The single-panel test is now available throughout the U.S. through doctors, hospitals, and other authorized healthcare providers.

LabCorp said it has also submitted an application to the U.S. Food and Drug Administration to offer the test through its Pixel by LabCorp at-home test collection kit.

LabCorp to offer total COVID-19 antibody testing for free
LabCorp plans to offer total antibody testing at no charge through patients' doctors in support of increased blood plasma donations for use as a possible...
LabCorp reports revenue dip in Q2
The COVID-19 pandemic resulted in a 3.9% drop in revenue for LabCorp in its second quarter.
LabCorp launches smart laboratory test reports
LabCorp has launched Insight Analytics, intelligent reports that combine national laboratory test values with patient demographics.
Humana offers LabCorp at-home COVID-19 test, partners with Walmart, Quest
Health insurer Humana is offering LabCorp's at-home COVID-19 test kit in a pilot home testing program for members. It has also formed a new collaboration...
LabCorp neutralizing antibody test could help screen recovered COVID-19 patients
LabCorp has launched a new neutralizing antibody test that it says will be useful in the development of vaccines and in screening the plasma of recovered...

Copyright © 2020 LabPulse.com

Last Updated ls 9/21/2020 8:33:33 AM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current